Abstract
Mastitis in dairy cows is generally considered to be the most expensive disease for dairy farmers worldwide. The overuse of antibiotics is a major problem in the treatment of bovine mastitis, and bacteriophage therapy is expected to provide an alternative treatment. The primary aim of this study was to evaluate the efficacy of a phage cocktail against mastitis in a mouse model. First, a Staphylococcus aureus strain was isolated from milk samples taken from mastitis cows from dairy farms in Xinjiang, China, and it was designated as Sau-XJ-21. Next, two phages (designated as vBSM-A1 and vBSP-A2) with strong lytic activity against Sau-XJ-21 were isolated from mixed sewage samples collected from three cattle farms in Xinjiang. Phages vBSM-A1 and vBSP-A2 were identified as members of the Myoviridae and Podoviridae families, respectively. The two phages exhibited a wide range of hosts, especially phage vBSM-A1. To evaluate the effectiveness of the two phages in the treatment against mastitis, female lactating mice were used 10–14 days after giving births. The mice were divided into six groups; one group was kept as healthy control, while the remaining five groups were inoculated with the isolated S. aureus strain to induce mastitis. Four hours after bacterial inoculation, mice in these groups were injected with 25 μL phosphate buffer saline (negative control), ceftiofur sodium (positive control), or phage, either individually or as a cocktail. The mice were sacrificed 20 h later, and the mammary glands were removed and subjected to further analysis, including the quantitation of colony-forming units (CFU), plaque-forming units (PFU), and gross macroscopic as well as histopathology observation. Mice with induced mastitis exhibited significantly improved mastitic pathology and decreased bacterial counts after they had been given phage treatments, with the phage cocktail being more superior than either phage alone. Furthermore, the cocktail treatment also maintained the highest intramammary phage titer without spreading systemically. The effectiveness of the phage cocktail was comparable to that produced by ceftiofur sodium. According to the data obtained for the mouse model of mastitis, phage therapy could be considered as an innovative alternative to antibiotics for the treatment of bovine mastitis.
Similar content being viewed by others
References
Abedon ST (2017) Commentary: communication between viruses guides lysis-lysogeny decisions. Front Microbiol 8:983
Abedon ST, Thomas AC (2010) Phage Therapy Pharmacology. Curr Pharm Biotechnol 11:28–47
Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM (2011) Phage treatment of human infections. Bacteriophage 1:66–85
Alemayehu D, Casey PG, McAuliffe O et al (2012) Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio 3:00029–00012
Anderson TF (1949) Bacteriophages. Annu Rev Microbiol 4:21–34
Azam H, Tanji Y (2019) Peculiarities of Staphylococcus aureus phages and their possible application in phage therapy. Appl Microbiol Biotechnol 103:4279–4289
Basanisi M, LaBella G, Nobili G, Franconieri I, Salandra G (2017) Genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolated from milk and dairy products in South Italy. Food Microbiol 62:141–146
Breyne K, Honaker R, Hobbs Z, Richter M, Żaczek M, Spangler T, Steenbrugge J, Lu R, Kinkhabwala A, Marchon B (2017) Efficacy and safety of a bovine-associated Staphylococcus aureus phage cocktail in a murine model of mastitis. Front Microbiol 8:1–27
Brouillette E, Malouin F (2005) The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect 7(3):560–568
Brüssow H (2005) Phage therapy:the Escherichia coli experience. Microbiology 151:2133–2140
Bryan D, Elshibiny A, Hobbs Z, Porter J, Kutter E (2016) Bacteriophage T4 infection of stationary phase E. coli: life after log from a phage perspective. Front Microbiol 7:11–29
Cao ZH, Zhang JC, Niu YD et al (2015) Isolation and characterization of a “phiKMV-like” bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia. PLoS One 10(l):0116571
Carlton RM (1999) Phage therapy: past history and future prospects. Arch Immunol Ther Exp (Warsz) 47(5):267–274
Chandler R (1970) Experimental bacterial mastitis in the mouse. J Med Microbiol 3(2):273–282
Donlan R M (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17(2):0–72
Doss J, Culbertson K, Hahn D, Camacho J, Barekzi N (2017) A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms. Viruses 9:50
Duarte VS, Dias R, Kropinski A, Campanaro S, Treu L, Siqueira C, Vieira M, Paes IS, Santana G, Martins F, Crispim J, Xavier A, Ferro C, Vidigal P, Silva C, Paula S (2018) Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows. Sci Rep 8:6845–6857
European Food Safety Authority (2009) Scientific report of EFSA prepared by the Animal Health and Animal Welfare Unit (AHAW) on the effect of farming systems on dairy cow welfare and disease. Annex EFSA J 284:1143
Gomes F, Henriques M (2016) Control of bovine mastitis: old and recent therapeutic approaches. Curr Microbiol 72:377–382. https://doi.org/10.1007/s00284-015-0958-8
Haran K, Godden S, Boxrud D, Jawahir S, Bender J, Sreevatsan S (2012) Prevalence and characterization of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, isolated from bulk tank milk from Minnesota dairy farms. J Clin Microbiol 50:688–695
Hermoso JA, Garcia JL, Garcia P (2007) Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr Opin Microbiol 10:461–472. https://doi.org/10.1016/j.mib.2007.08.002
Hertl J, Gröhn Y, Leach J et al (2010) Effects of clinical mastitis caused by gram-positive and gram-negative bacteria and other organisms on the probability of conception in New York State Holstein dairy cows. J Dairy Sci 93:1551–1560
Iwano H, Inoue Y, Takasago T et al (2018) Bacteriophage φA012 has a broad host range against Staphylococcus aureus and effective lytic capacity in a mouse mastitis model. Biology 7:1–13
Jamali H, Barkema HW, Jacques M, Lavallée-Bourget EM, Malouin F, Saini V, Stryhn H, Dufour S (2018) Invited review: incidence, risk factors, and effects of clinical mastitis recurrence in dairy cows. J Dairy Sci 101(6):4729–4746
Jennes S, Merabishvili M, Soentjens P, Pang KW, Rose T, Keersebilck E, Soete O, François P, Teodorescu S, Verween G, Verbeken G, Daniel D, Pirnay J (2017) Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report. Crit Care 21:129–130
Kawa Z, Skrobek G, Maciejewska B, Delattre A, Lavigne R (2012) Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci 13:699–722
Kim M, Ryu S (2011) Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar typhimurium and Escherichia coli. Appl Environ Microbiol 77:2042–2050
Koen B, Ryan W, Zachary H et al (2017) Efficacy and safety of a bovine-associated Staphylococcus aureus phage cocktail in a murine model of mastitis. Front Microbiol 8(11):1–11
Kumaran D, Taha M, Yi Q et al (2018) Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms. Front Microbiol 9(2):1–11
Kutter E, De VD, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11(1):69–86
Labrie S, Samson J, Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317–327
Leaver SK, Evans TW (2007) Acute respiratory distress syndrome. BMJ 335:389–394. https://doi.org/10.1136/bmj.39293.624699.AD
Lenski RE, Levin BR (1985) Constraints on the coevolution of bacteria and virulent phage: a model, some experiments, and predictions for natural communities. Am Nat 125:585–602
Letarov A, Kulikov E (2010) The bacteriophages in human and animal body associated microbial communities. J Appl Microbiol 107(1):1–13
Li Y (2014) Experimental study of Staphylococcus aureus lytic bacteriophage in the treatment of mastitis. Jilin University
Li Z, Li X, Zhang J, Wang X, Wang L, Cao Z, Xu Y (2016) Use of phages to control Vibrio splendidus infection in the juvenile sea cucumber Apostichopus japonicus. Fish Shellfish Immunol 54:302–311
Liu H, Niu YD, Li J, Stanford K, McAllister TA (2013) In-vitro efficacy of bacteriophages T5, T4, T1 and O1 against E. coli O157:H7. Joint Canadian Society of Animal Science and Canadian Meat Science Association Congress. Banff Canada
Liu H, Li S, Meng L, Dong L, Zhao S, Lan X, Wang J, Zheng N (2017) Prevalence, antimicrobial susceptibility, and molecular characterization of Staphylococcus aureus isolated from dairy herds in northern China. J Dairy Sci 100:8796–8803
Loessner MJ (2005) Bacteriophage endolysins-current state of research and applications. Curr Opin Biotechnol 8(4):480–487
MacNeal WJ, Frisbee FC (1936) One hundred patients with Staphylococcus septicemia receiving bacteriophage service. Am J Med Sci 191:179–195
Maskrey BH, Megson IL, Whitfield PD, Rossi AG (2011) Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler Thromb Vasc Biol 31:1001–1006. https://doi.org/10.1161/ATVBAHA.110.213850
Michael CA, Dominey-Howes D, Labbate M (2014) The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health 2:145. https://doi.org/10.3389/fpubh.2014.00145
Międzybrodzki R, Fortuna W, Weber-Dąbrowska B, Górski A (2009) A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med 9:303–312
Misra N, Wines TF, Knopp CL, Hermann R, Bond L, Mitchell B, McGuire MA, Tinker JK (2018) Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis. Vaccine 36:3513–3521
Norrby SR, Nord CE, Finch R (2005) Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5:115–119. https://doi.org/10.1016/S1473-3099(05)01283–1
Notebaert S, Meyer E (2006) Mouse models to study the pathogenesis and control of bovine mastitis. A review. Vet Q 28:2–13
Ogawa M (1998) Acute pancreatitis and cytokines: second attack by septic complication leads to organ failure. Pancreas 16:312–315. https://doi.org/10.1097/00006676-199804000-00017
Ouyang P (2009) Expression of human lysozyme-antibacterial peptide fusion protein and its efficacy of treating mouse mastitis. Jilin University
Petitclerc D, Lauzon K, Cochu A, Ster C, Diarra MS, Lacasse P (2007) Efficacy of a lactoferrin-penicillin combination to treat {beta}-lactam-resistant Staphylococcus aureus mastitis. J Dairy Sci 90:2778–2787
Roches A, Lussert A, Faure M et al (2018) Dairy cows under experimentally-induced Escherichia coli mastitis show T negative emotional states assessed through Qualitative Behaviour Assessment. Appl Anim Behav Sci 206:1–11
Schmeck B, Moog K, Zahlten J, van Laak V, N’Guessan PD, Opitz B, Rosseau S, Suttorp N, Hippenstiel S (2006) Streptococcus pneumoniae- induced c-Jun-N-terminal kinase-and AP-1-dependent IL-8 release by lung epithelial BEAS-2B cells. Respir Res 7:98
Schmelcher M et al (2012) Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. Appl Environ Microbiol 27:2297–2305
Schultz EW (1929) The bacteriophage as a therapeutic agent. Cal West Med 31:5–10
Sender G, Pawlik A, Korwin KA (2017) Current concepts on the impact of coagulase-negative staphylococci causing bovine mastitis as a threat to human and animal health – a review. Anim Sci Paper Rep 35(2):123–135
Sidjabat H, Nimmo GR, Walsh TR, Binotto E, Htin A, Hayashi Y, Li J, Nation RL, George N, Paterson DL (2011) Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo- lactamase. Clin Infect Dis 52:481–484. https://doi.org/10.1093/cid/ciq178
Taghavi M, Mortaz E, Khosravi A, Vahedi G, Folkerts G, Varahram M, Kazempour-Dizaji M, Garssen J, Adcock IM (2018) Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice. J Inflamm-Lond 15:5
Tuchscherr L, Buzzola F, Alvarez L et al (2005) Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice. Infect Immun 73:7932–7937
Twort FW (1915) An investigation on the nature of ultra-microscopic viruses. Lancet 189:1241–1243
Varela DF, Barboza JE, González J et al (2018) Antibiotic susceptibility of Staphylococcus aureus isolated from subclinical bovine mastitis cases and in vitro efficacy of bacteriophage. Vet Res Commun 42:243–250
Wall RJ, Powell AM, Paape MJ, Kerr DE, Bannerman DD, Pursel VG, Wells KD, Talbot N, Hawk HW (2005) Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 23:445–451
Wright A, Hawkins C, Anggård E, Harper D (2009) A con-trolled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34:349–357
Xia F, Li X, Wang B et al (2016) Combination therapy of LysGH15 and apigenin as a new strategy for treating pneumonia caused by Staphylococcus aureus. Appl Environ Microbiol 1(82):87–94
Xiao F (2015) Experimental study of Staphylococcus aureus phage lysin LysGH15 in the treatment of mastitis. Jilin University
Zandkarimi F, Vanegas J, Fern X, Maier CS, Bobe G (2018) Metabo types with elevated protein and lipid catabolism and inflammation precede clinical mastitis in prepartal transition dairy cows. J Dairy Sci 101(6):5531–5548
Zhang YP (2017) China’s dairy quality continued to improve the construction of modern dairy industry steadily - China dairy quality report. Infect Immun 14–15
Zhang JC, Cao ZH, Li Z, Wang L, Li H, Wu F, Jin LJ, Li XY, Li SY, Xu YP (2015) Effect of bacteriophages on Vibrio alginolyticus infection in the sea cucumber, Apostichopus japonicus (Selenka)[J]. J World Aquacult Soc 46(2):149–158
Funding
This work was supported by the National Key R&D Program of China (No. 2018YFD0500600) and the National Public Science and Technology Research Funds Projects of Ocean (Grant No. 201405003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Geng, H., Zou, W., Zhang, M. et al. Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice. Folia Microbiol 65, 339–351 (2020). https://doi.org/10.1007/s12223-019-00729-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-019-00729-9